AMPRIUS TECHNOLOGIES INC (AMPX)

US03214Q1085 - Common Stock

1.82  +0.12 (+7.06%)

After market: 1.84 +0.02 (+1.1%)

Fundamental Rating

4

Taking everything into account, AMPX scores 4 out of 10 in our fundamental rating. AMPX was compared to 88 industry peers in the Electrical Equipment industry. While AMPX has a great health rating, there are worries on its profitability. AMPX shows excellent growth, but is valued quite expensive already.



0

1. Profitability

1.1 Basic Checks

AMPX had negative earnings in the past year.
AMPX had a negative operating cash flow in the past year.

1.2 Ratios

Looking at the Return On Assets, with a value of -34.13%, AMPX is doing worse than 64.77% of the companies in the same industry.
Looking at the Return On Equity, with a value of -61.49%, AMPX is in line with its industry, outperforming 40.91% of the companies in the same industry.
Industry RankSector Rank
ROA -34.13%
ROE -61.49%
ROIC N/A
ROA(3y)-36.13%
ROA(5y)N/A
ROE(3y)-52.22%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

AMPX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

7

2. Health

2.1 Basic Checks

AMPX does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, AMPX has more shares outstanding
There is no outstanding debt for AMPX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

AMPX has an Altman-Z score of -0.12. This is a bad value and indicates that AMPX is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of AMPX (-0.12) is comparable to the rest of the industry.
There is no outstanding debt for AMPX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -0.12
ROIC/WACCN/A
WACC10.02%

2.3 Liquidity

AMPX has a Current Ratio of 3.75. This indicates that AMPX is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of AMPX (3.75) is better than 84.09% of its industry peers.
AMPX has a Quick Ratio of 3.70. This indicates that AMPX is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 3.70, AMPX belongs to the top of the industry, outperforming 88.64% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.75
Quick Ratio 3.7

7

3. Growth

3.1 Past

The earnings per share for AMPX have decreased strongly by -15.38% in the last year.
The Revenue has grown by 105.28% in the past year. This is a very strong growth!
The Revenue has been growing by 24.60% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-15.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)105.28%
Revenue growth 3Y24.6%
Revenue growth 5YN/A
Sales Q2Q%180.74%

3.2 Future

Based on estimates for the next years, AMPX will show a quite strong growth in Earnings Per Share. The EPS will grow by 17.22% on average per year.
The Revenue is expected to grow by 123.06% on average over the next years. This is a very strong growth
EPS Next Y-8.17%
EPS Next 2Y2.29%
EPS Next 3Y26.16%
EPS Next 5Y17.22%
Revenue Next Year134.9%
Revenue Next 2Y190.23%
Revenue Next 3Y213.89%
Revenue Next 5Y123.06%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AMPX. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AMPX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as AMPX's earnings are expected to grow with 26.16% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y2.29%
EPS Next 3Y26.16%

0

5. Dividend

5.1 Amount

No dividends for AMPX!.
Industry RankSector Rank
Dividend Yield N/A

AMPRIUS TECHNOLOGIES INC

NYSE:AMPX (12/20/2024, 8:04:00 PM)

After market: 1.84 +0.02 (+1.1%)

1.82

+0.12 (+7.06%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)N/A N/A
Inst Owners7.42%
Inst Owner Change1.35%
Ins Owners65.18%
Ins Owner Change0.16%
Market Cap192.63M
Analysts81.54
Price Target6.73 (269.78%)
Short Float %4.23%
Short Ratio1.33
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.37%
Min EPS beat(2)4.45%
Max EPS beat(2)18.3%
EPS beat(4)3
Avg EPS beat(4)2.83%
Min EPS beat(4)-15.55%
Max EPS beat(4)18.3%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)186.75%
Min Revenue beat(2)43.21%
Max Revenue beat(2)330.3%
Revenue beat(4)4
Avg Revenue beat(4)148.86%
Min Revenue beat(4)9.73%
Max Revenue beat(4)330.3%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-7.91%
PT rev (3m)-7.91%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)8.49%
EPS NY rev (3m)-16.92%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)24.49%
Revenue NY rev (3m)-20.38%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 21.28
P/FCF N/A
P/OCF N/A
P/B 3.22
P/tB 3.22
EV/EBITDA N/A
EPS(TTM)-0.45
EYN/A
EPS(NY)-0.41
Fwd EYN/A
FCF(TTM)-0.41
FCFYN/A
OCF(TTM)-0.24
OCFYN/A
SpS0.09
BVpS0.57
TBVpS0.57
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -34.13%
ROE -61.49%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-36.13%
ROA(5y)N/A
ROE(3y)-52.22%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 971.76%
Cap/Sales 193.84%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.75
Quick Ratio 3.7
Altman-Z -0.12
F-Score3
WACC10.02%
ROIC/WACCN/A
Cap/Depr(3y)370.08%
Cap/Depr(5y)N/A
Cap/Sales(3y)83.15%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-15.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y-8.17%
EPS Next 2Y2.29%
EPS Next 3Y26.16%
EPS Next 5Y17.22%
Revenue 1Y (TTM)105.28%
Revenue growth 3Y24.6%
Revenue growth 5YN/A
Sales Q2Q%180.74%
Revenue Next Year134.9%
Revenue Next 2Y190.23%
Revenue Next 3Y213.89%
Revenue Next 5Y123.06%
EBIT growth 1Y-114.54%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-11.35%
EBIT Next 3Y41.21%
EBIT Next 5Y38.7%
FCF growth 1Y-180.62%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-84.1%
OCF growth 3YN/A
OCF growth 5YN/A